BRPI0618972A2 - Métodos de medição da atividade imunológica e para quantificação da quantidade de enzima alergênica em uma preparação de vacina - Google Patents

Métodos de medição da atividade imunológica e para quantificação da quantidade de enzima alergênica em uma preparação de vacina Download PDF

Info

Publication number: BRPI0618972A2
Authority: BR; Brazil
Prior art keywords: enzyme; activity; aluminum hydroxide; allergenic; der
Prior art date: 2005-11-24

Application number

BRPI0618972-5A

Other languages

English (en)

Portuguese (pt)

Inventor

Maria Mercedes Ferreira Gomez

Morten Jonas Maltesen

Rasmus Linnemann Krogh

Original Assignee

Alk Abello As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-24

Filing date

2006-11-23

Publication date

2011-09-20

2006-11-23 Application filed by Alk Abello As filed Critical Alk Abello As

2006-11-23 Priority claimed from PCT/DK2006/000656 external-priority patent/WO2007059776A1/en

2011-09-20 Publication of BRPI0618972A2 publication Critical patent/BRPI0618972A2/pt

Links

102000004190 Enzymes Human genes 0.000 title claims abstract description 144
108090000790 Enzymes Proteins 0.000 title claims abstract description 144
229960005486 vaccine Drugs 0.000 title claims abstract description 79
238000002360 preparation method Methods 0.000 title claims abstract description 78
238000000034 method Methods 0.000 title claims abstract description 58
230000001900 immune effect Effects 0.000 title claims abstract description 32
206010020751 Hypersensitivity Diseases 0.000 title description 12
208000026935 allergic disease Diseases 0.000 title description 12
230000007815 allergy Effects 0.000 title description 9
230000002009 allergenic effect Effects 0.000 claims abstract description 84
238000005259 measurement Methods 0.000 claims abstract description 76
230000002255 enzymatic effect Effects 0.000 claims abstract description 61
239000007790 solid phase Substances 0.000 claims abstract description 48
239000000203 mixture Substances 0.000 claims abstract description 45
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 40
229910052760 oxygen Inorganic materials 0.000 claims abstract description 40
239000001301 oxygen Substances 0.000 claims abstract description 40
150000003839 salts Chemical class 0.000 claims abstract description 35
229910052751 metal Inorganic materials 0.000 claims abstract description 34
239000002184 metal Substances 0.000 claims abstract description 34
239000002671 adjuvant Substances 0.000 claims abstract description 29
239000007791 liquid phase Substances 0.000 claims abstract description 28
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical group [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 150
230000000694 effects Effects 0.000 claims description 91
239000000758 substrate Substances 0.000 claims description 72
238000003556 assay Methods 0.000 claims description 26
108010005843 Cysteine Proteases Proteins 0.000 claims description 23
102000005927 Cysteine Proteases Human genes 0.000 claims description 23
239000003112 inhibitor Substances 0.000 claims description 16
239000000284 extract Substances 0.000 claims description 15
108010022999 Serine Proteases Proteins 0.000 claims description 5
102000012479 Serine Proteases Human genes 0.000 claims description 5
238000001952 enzyme assay Methods 0.000 abstract description 19
229940024545 aluminum hydroxide Drugs 0.000 description 149
229940088598 enzyme Drugs 0.000 description 123
235000018102 proteins Nutrition 0.000 description 88
102000004169 proteins and genes Human genes 0.000 description 88
108090000623 proteins and genes Proteins 0.000 description 87
239000013566 allergen Substances 0.000 description 76
239000004365 Protease Substances 0.000 description 53
238000001179 sorption measurement Methods 0.000 description 46
108090000526 Papain Proteins 0.000 description 43
229940055729 papain Drugs 0.000 description 43
235000019834 papain Nutrition 0.000 description 43
229960004784 allergens Drugs 0.000 description 33
238000002474 experimental method Methods 0.000 description 31
239000000243 solution Substances 0.000 description 28
239000000523 sample Substances 0.000 description 22
230000027455 binding Effects 0.000 description 19
238000012360 testing method Methods 0.000 description 19
239000000872 buffer Substances 0.000 description 18
239000000499 gel Substances 0.000 description 18
102000035195 Peptidases Human genes 0.000 description 16
108091005804 Peptidases Proteins 0.000 description 16
230000006870 function Effects 0.000 description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
238000002835 absorbance Methods 0.000 description 14
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 14
230000008859 change Effects 0.000 description 13
108090000765 processed proteins & peptides Proteins 0.000 description 12
102000036639 antigens Human genes 0.000 description 11
108091007433 antigens Proteins 0.000 description 11
239000013543 active substance Substances 0.000 description 10
239000000427 antigen Substances 0.000 description 10
230000003197 catalytic effect Effects 0.000 description 10
238000000746 purification Methods 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
238000010521 absorption reaction Methods 0.000 description 9
235000001014 amino acid Nutrition 0.000 description 9
229940024606 amino acid Drugs 0.000 description 9
150000001413 amino acids Chemical class 0.000 description 9
238000001543 one-way ANOVA Methods 0.000 description 9
238000004448 titration Methods 0.000 description 9
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
239000008363 phosphate buffer Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
238000000926 separation method Methods 0.000 description 8
229910052782 aluminium Inorganic materials 0.000 description 7
239000000428 dust Substances 0.000 description 7
238000011534 incubation Methods 0.000 description 7
230000003993 interaction Effects 0.000 description 7
230000007246 mechanism Effects 0.000 description 7
238000004062 sedimentation Methods 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
239000007983 Tris buffer Substances 0.000 description 6
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 6
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
238000006555 catalytic reaction Methods 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
238000007824 enzymatic assay Methods 0.000 description 6
239000011521 glass Substances 0.000 description 6
230000005764 inhibitory process Effects 0.000 description 6
239000000463 material Substances 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
101100422770 Caenorhabditis elegans sup-1 gene Proteins 0.000 description 5
-1 Cys anion thiolate Chemical class 0.000 description 5
241000238740 Dermatophagoides pteronyssinus Species 0.000 description 5
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
239000011543 agarose gel Substances 0.000 description 5
OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
235000018417 cysteine Nutrition 0.000 description 5
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
238000010828 elution Methods 0.000 description 5
239000013573 pollen allergen Substances 0.000 description 5
235000019419 proteases Nutrition 0.000 description 5
230000007017 scission Effects 0.000 description 5
239000000126 substance Substances 0.000 description 5
FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
108010059378 Endopeptidases Proteins 0.000 description 4
102000005593 Endopeptidases Human genes 0.000 description 4
241000257303 Hymenoptera Species 0.000 description 4
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
238000011481 absorbance measurement Methods 0.000 description 4
229940024546 aluminum hydroxide gel Drugs 0.000 description 4
SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
150000001450 anions Chemical class 0.000 description 4
239000003054 catalyst Substances 0.000 description 4
239000003638 chemical reducing agent Substances 0.000 description 4
229910052739 hydrogen Inorganic materials 0.000 description 4
239000001257 hydrogen Substances 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
238000011835 investigation Methods 0.000 description 4
238000002156 mixing Methods 0.000 description 4
239000012071 phase Substances 0.000 description 4
239000002574 poison Substances 0.000 description 4
231100000614 poison Toxicity 0.000 description 4
230000002797 proteolythic effect Effects 0.000 description 4
238000011002 quantification Methods 0.000 description 4
238000003860 storage Methods 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000012546 transfer Methods 0.000 description 4
229920000936 Agarose Polymers 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 3
238000000692 Student's t-test Methods 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000000172 allergic effect Effects 0.000 description 3
208000010668 atopic eczema Diseases 0.000 description 3
230000008901 benefit Effects 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
230000007423 decrease Effects 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
230000009881 electrostatic interaction Effects 0.000 description 3
229940066758 endopeptidases Drugs 0.000 description 3
238000000605 extraction Methods 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
239000002245 particle Substances 0.000 description 3
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
235000019833 protease Nutrition 0.000 description 3
230000004224 protection Effects 0.000 description 3
230000017854 proteolysis Effects 0.000 description 3
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000011550 stock solution Substances 0.000 description 3
238000012353 t test Methods 0.000 description 3
230000007704 transition Effects 0.000 description 3
238000007492 two-way ANOVA Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
FOYHOBVZPWIGJM-KCHLEUMXSA-N (4s)-4-[[(2s)-4-methyl-2-[[(2s)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]pentanoyl]amino]-5-[(4-methyl-2-oxochromen-7-yl)amino]-5-oxopentanoic acid Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NC=1C=C2OC(=O)C=C(C)C2=CC=1)C(=O)OCC1=CC=CC=C1 FOYHOBVZPWIGJM-KCHLEUMXSA-N 0.000 description 2
241000238876 Acari Species 0.000 description 2
238000000846 Bartlett's test Methods 0.000 description 2
241001674044 Blattodea Species 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
101000749287 Clitocybe nebularis Clitocypin Proteins 0.000 description 2
101000767029 Clitocybe nebularis Clitocypin-1 Proteins 0.000 description 2
229940094664 Cysteine protease inhibitor Drugs 0.000 description 2
241000238710 Dermatophagoides Species 0.000 description 2
108010061629 Dermatophagoides pteronyssinus antigen p 1 Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
102000018389 Exopeptidases Human genes 0.000 description 2
108010091443 Exopeptidases Proteins 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 2
108010073816 IgE Receptors Proteins 0.000 description 2
102000009438 IgE Receptors Human genes 0.000 description 2
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 2
241000579835 Merops Species 0.000 description 2
102000005741 Metalloproteases Human genes 0.000 description 2
108010006035 Metalloproteases Proteins 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
241000009328 Perro Species 0.000 description 2
241000209504 Poaceae Species 0.000 description 2
102000001708 Protein Isoforms Human genes 0.000 description 2
108010029485 Protein Isoforms Proteins 0.000 description 2
FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000008186 active pharmaceutical agent Substances 0.000 description 2
230000000240 adjuvant effect Effects 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
208000030961 allergic reaction Diseases 0.000 description 2
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 2
150000001449 anionic compounds Chemical class 0.000 description 2
238000000149 argon plasma sintering Methods 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
239000013068 control sample Substances 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000007515 enzymatic degradation Effects 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
210000003608 fece Anatomy 0.000 description 2
239000013568 food allergen Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000013574 grass pollen allergen Substances 0.000 description 2
235000008216 herbs Nutrition 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
125000001165 hydrophobic group Chemical group 0.000 description 2
150000004679 hydroxides Chemical class 0.000 description 2
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
230000017555 immunoglobulin mediated immune response Effects 0.000 description 2
229910001412 inorganic anion Inorganic materials 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
238000012417 linear regression Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
150000002891 organic anions Chemical class 0.000 description 2
150000002924 oxiranes Chemical group 0.000 description 2
230000007170 pathology Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
230000002685 pulmonary effect Effects 0.000 description 2
239000010453 quartz Substances 0.000 description 2
230000004044 response Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
239000007787 solid Substances 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
238000003756 stirring Methods 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
239000002753 trypsin inhibitor Substances 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
238000002255 vaccination Methods 0.000 description 2
239000002699 waste material Substances 0.000 description 2
239000011667 zinc carbonate Substances 0.000 description 2
235000004416 zinc carbonate Nutrition 0.000 description 2
229910000010 zinc carbonate Inorganic materials 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
CGWBIHLHAGNJCX-UHFFFAOYSA-N 2-butylguanidine Chemical compound CCCCNC(N)=N CGWBIHLHAGNJCX-UHFFFAOYSA-N 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
241000219496 Alnus Species 0.000 description 1
241000223600 Alternaria Species 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
241000256837 Apidae Species 0.000 description 1
101100028789 Arabidopsis thaliana PBS1 gene Proteins 0.000 description 1
241000239290 Araneae Species 0.000 description 1
241000238421 Arthropoda Species 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
108091005502 Aspartic proteases Proteins 0.000 description 1
102000035101 Aspartic proteases Human genes 0.000 description 1
241000208837 Asterales Species 0.000 description 1
102100025142 Beta-microseminoprotein Human genes 0.000 description 1
241000219429 Betula Species 0.000 description 1
235000003932 Betula Nutrition 0.000 description 1
235000018185 Betula X alpestris Nutrition 0.000 description 1
235000018212 Betula X uliginosa Nutrition 0.000 description 1
241000219495 Betulaceae Species 0.000 description 1
241000238658 Blattella Species 0.000 description 1
241000339490 Brachyachne Species 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
240000006432 Carica papaya Species 0.000 description 1
241000726768 Carpinus Species 0.000 description 1
102100035904 Caspase-1 Human genes 0.000 description 1
108090000426 Caspase-1 Proteins 0.000 description 1
102000005600 Cathepsins Human genes 0.000 description 1
108010084457 Cathepsins Proteins 0.000 description 1
241000218645 Cedrus Species 0.000 description 1
241000256128 Chironomus <genus> Species 0.000 description 1
241000222290 Cladosporium Species 0.000 description 1
241000723382 Corylus Species 0.000 description 1
235000001543 Corylus americana Nutrition 0.000 description 1
240000007582 Corylus avellana Species 0.000 description 1
235000007466 Corylus avellana Nutrition 0.000 description 1
240000005109 Cryptomeria japonica Species 0.000 description 1
241000252233 Cyprinus carpio Species 0.000 description 1
241000209210 Dactylis Species 0.000 description 1
208000001840 Dandruff Diseases 0.000 description 1
102000010911 Enzyme Precursors Human genes 0.000 description 1
108010062466 Enzyme Precursors Proteins 0.000 description 1
241000238739 Euroglyphus Species 0.000 description 1
241000238741 Euroglyphus maynei Species 0.000 description 1
241000219427 Fagales Species 0.000 description 1
108091005503 Glutamic proteases Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
241001510533 Glycyphagus Species 0.000 description 1
241000744855 Holcus Species 0.000 description 1
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
101100185029 Homo sapiens MSMB gene Proteins 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
102000004157 Hydrolases Human genes 0.000 description 1
108090000604 Hydrolases Proteins 0.000 description 1
RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
241000721662 Juniperus Species 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
235000003805 Musa ABB Group Nutrition 0.000 description 1
240000008790 Musa x paradisiaca Species 0.000 description 1
241000795633 Olea <sea slug> Species 0.000 description 1
240000007817 Olea europaea Species 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000238661 Periplaneta Species 0.000 description 1
241000745991 Phalaris Species 0.000 description 1
241000746981 Phleum Species 0.000 description 1
241000218633 Pinidae Species 0.000 description 1
235000015266 Plantago major Nutrition 0.000 description 1
241000209464 Platanaceae Species 0.000 description 1
241000209466 Platanus Species 0.000 description 1
241000209048 Poa Species 0.000 description 1
241001536628 Poales Species 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
241001534493 Pteronyssus Species 0.000 description 1
241000238711 Pyroglyphidae Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
241000220317 Rosa Species 0.000 description 1
241000220221 Rosales Species 0.000 description 1
241000239226 Scorpiones Species 0.000 description 1
241000209056 Secale Species 0.000 description 1
108010031091 Separase Proteins 0.000 description 1
102000005734 Separase Human genes 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
235000011684 Sorghum saccharatum Nutrition 0.000 description 1
240000006694 Stellaria media Species 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
238000003639 Student–Newman–Keuls (SNK) method Methods 0.000 description 1
230000005867 T cell response Effects 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
229940122618 Trypsin inhibitor Drugs 0.000 description 1
101710162629 Trypsin inhibitor Proteins 0.000 description 1
241000132125 Tyrophagus Species 0.000 description 1
238000005411 Van der Waals force Methods 0.000 description 1
241000256856 Vespidae Species 0.000 description 1
238000004847 absorption spectroscopy Methods 0.000 description 1
238000000862 absorption spectrum Methods 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
229940074608 allergen extract Drugs 0.000 description 1
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
239000012911 assay medium Substances 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
229960002319 barbital Drugs 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
229910052790 beryllium Inorganic materials 0.000 description 1
WPJWIROQQFWMMK-UHFFFAOYSA-L beryllium dihydroxide Chemical compound [Be+2].[OH-].[OH-] WPJWIROQQFWMMK-UHFFFAOYSA-L 0.000 description 1
229910001865 beryllium hydroxide Inorganic materials 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
229940088623 biologically active substance Drugs 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000012496 blank sample Substances 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Chemical class [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
239000008364 bulk solution Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
239000001527 calcium lactate Substances 0.000 description 1
235000011086 calcium lactate Nutrition 0.000 description 1
229960002401 calcium lactate Drugs 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
238000011210 chromatographic step Methods 0.000 description 1
238000011097 chromatography purification Methods 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
238000003271 compound fluorescence assay Methods 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000012864 cross contamination Methods 0.000 description 1
230000020176 deacylation Effects 0.000 description 1
238000005947 deacylation reaction Methods 0.000 description 1
238000005034 decoration Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000000113 differential scanning calorimetry Methods 0.000 description 1
229940079919 digestives enzyme preparation Drugs 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000012636 effector Substances 0.000 description 1
JROGBPMEKVAPEH-GXGBFOEMSA-N emetine dihydrochloride Chemical compound Cl.Cl.N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC JROGBPMEKVAPEH-GXGBFOEMSA-N 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
210000001508 eye Anatomy 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
102000034238 globular proteins Human genes 0.000 description 1
108091005896 globular proteins Proteins 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
238000012388 gravitational sedimentation Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
229940046533 house dust mites Drugs 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000000899 immune system response Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000007689 inspection Methods 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
ICIWUVCWSCSTAQ-UHFFFAOYSA-N iodic acid Chemical class OI(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-N 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
230000031700 light absorption Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
229940099076 maalox Drugs 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
229940062713 mite extract Drugs 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000010606 normalization Methods 0.000 description 1
210000001331 nose Anatomy 0.000 description 1
239000012038 nucleophile Substances 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
239000002674 ointment Substances 0.000 description 1
238000005457 optimization Methods 0.000 description 1
150000003891 oxalate salts Chemical class 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000035699 permeability Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
108091005981 phosphorylated proteins Proteins 0.000 description 1
239000004033 plastic Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000008569 process Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000004952 protein activity Effects 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
102200142361 rs79011243 Human genes 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
239000012898 sample dilution Substances 0.000 description 1
239000013049 sediment Substances 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000012192 staining solution Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000013595 supernatant sample Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
150000003892 tartrate salts Chemical class 0.000 description 1
150000003568 thioethers Chemical class 0.000 description 1
210000001578 tight junction Anatomy 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
229940046536 tree pollen allergenic extract Drugs 0.000 description 1
125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
210000001215 vagina Anatomy 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
235000014393 valine Nutrition 0.000 description 1
125000002987 valine group Chemical class [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/20—Coumarin derivatives
- C12Q2337/22—7-Amino-4-methylcoumarin, i.e. AMC, MCA

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Microbiology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Biophysics (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

BRPI0618972-5A 2005-11-24 2006-11-23 Métodos de medição da atividade imunológica e para quantificação da quantidade de enzima alergênica em uma preparação de vacina BRPI0618972A2 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DKPA200501655		2005-11-24
DKPA200501655		2005-11-24
US73940805P	2005-11-25	2005-11-25
US60/739,408		2005-11-25
PCT/DK2006/000656 WO2007059776A1 (en)	2005-11-24	2006-11-23	A method of measuring enzymatic activity of adsorbed allergenic enzyme

Publications (1)

Publication Number	Publication Date
BRPI0618972A2 true BRPI0618972A2 (pt)	2011-09-20

Family

ID=36092464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0618972-5A BRPI0618972A2 (pt)	2005-11-24	2006-11-23	Métodos de medição da atividade imunológica e para quantificação da quantidade de enzima alergênica em uma preparação de vacina

Country Status (6)

Country	Link
CN (1)	CN101351561B (es)
BR (1)	BRPI0618972A2 (es)
DE (1)	DE602006016000D1 (es)
DK (1)	DK1957661T3 (es)
ES (1)	ES2349672T3 (es)
PT (1)	PT1957661E (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110665000B (zh) *	2018-07-02	2022-11-11	厦门大学	锌铝复合佐剂的制备及作为疫苗佐剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9724531D0 (en) *	1997-11-19	1998-01-21	Smithkline Biolog	Novel compounds
DK1649287T3 (da) *	2003-08-05	2008-11-24	Alk Abello As	Evaluering af vacciner med adjuvans

2006
- 2006-11-23 ES ES06805594T patent/ES2349672T3/es active Active
- 2006-11-23 BR BRPI0618972-5A patent/BRPI0618972A2/pt not_active IP Right Cessation
- 2006-11-23 CN CN2006800501653A patent/CN101351561B/zh not_active Expired - Fee Related
- 2006-11-23 PT PT06805594T patent/PT1957661E/pt unknown
- 2006-11-23 DK DK06805594.6T patent/DK1957661T3/da active
- 2006-11-23 DE DE602006016000T patent/DE602006016000D1/de active Active

Also Published As

Publication number	Publication date
ES2349672T3 (es)	2011-01-10
CN101351561A (zh)	2009-01-21
DK1957661T3 (da)	2010-11-29
CN101351561B (zh)	2013-07-17
PT1957661E (pt)	2010-11-04
DE602006016000D1 (de)	2010-09-16

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application fees: dismissal - article 86 of industrial property law	Free format text: REFERENTE A 9A ANUIDADE.
2016-03-29	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
Meng et al.	2019	Recent developments and highlights in allergic rhinitis
de Graaf et al.	2021	Standard methods for Apis mellifera venom research
Takabayashi et al.	2012	Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps
Gough et al.	2003	Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model
Guzman	2000	Determination of immunoreactive gonadotropin-releasing hormone in serum and urine by on-line immunoaffinity capillary electrophoresis coupled to mass spectrometry
McLaughlin et al.	2006	Proteomic analysis of microglial contribution to mouse strain–dependent dopaminergic neurotoxicity
US9274114B2 (en)	2016-03-01	Prostate kallikrein allergen
KR102194995B1 (ko)	2020-12-28	진단을 위한 개선된 건조체액의 안정화 조성물 및 이의 응용방법
ES2402286B1 (es)	2014-03-04	Péptido inmunogénico del gluten y sus aplicaciones.
CN102667487A (zh)	2012-09-12	碱性肽的检测方法及碱性肽检测用试剂
BRPI0618972A2 (pt)	2011-09-20	Métodos de medição da atividade imunológica e para quantificação da quantidade de enzima alergênica em uma preparação de vacina
US8492099B2 (en)	2013-07-23	Method of measuring enzymatic activity of adsorbed allergenic enzyme
Arora et al.	2012	Eosinophilic esophagitis: allergic contribution, testing, and management
Sehgal et al.	2005	Potential roles in rhinitis for protease and other enzymatic activities of allergens
US11013781B2 (en)	2021-05-25	Peptide combinations and uses thereof for treating grass allergy
Lund et al.	2006	Association of MBP peptides with Hsp70 in normal appearing human white matter
Yang et al.	2026	GPX4 promotes optic nerve regeneration and retinal ganglion cell neuroprotection
HK1120084B (en)	2010-11-19	A method of measuring enzymatic activity of adsorbed allergenic enzyme
ES2238487T3 (es)	2005-09-01	Variantes de la proteina alergica phl p1 de phleum pratense.
CN109734792A (zh)	2019-05-10	人cntn1抗原、人cntn1抗体检测试剂盒及其制备方法与应用
Schoumacher et al.	1992	Binding of RNA by the alfalfa mosaic virus movement protein is biphasic
Takemoto et al.	1975	Subunits of phycoerythrin from Fremyella diplosiphon. Chemical and immunochemical characterization
CN1928556A (zh)	2007-03-14	中国人2型糖尿病血清标志物的检测试剂盒
CN101909646A (zh)	2010-12-08	用于粘膜施用的过敏症疫苗组合物
JP5123858B2 (ja)	2013-01-23	ＩｇＥに結合する薬剤